1. Involvement of WNT2 in trophoblast cell behavior in preeclampsia development
- Author
-
Yufang Liu, Ning Yu, Junzhi Huang, Zhiqiang Liu, and Shuangyan Wei
- Subjects
0301 basic medicine ,Biology ,Preeclampsia ,Cell Line ,Wnt2 Protein ,03 medical and health sciences ,0302 clinical medicine ,Pre-Eclampsia ,WNT2 ,Cell Movement ,Pregnancy ,medicine ,Humans ,Molecular Biology ,reproductive and urinary physiology ,beta Catenin ,Gene knockdown ,Messenger RNA ,Trophoblast ,Cell Biology ,medicine.disease ,In vitro ,female genital diseases and pregnancy complications ,Trophoblasts ,030104 developmental biology ,medicine.anatomical_structure ,Apoptosis ,030220 oncology & carcinogenesis ,Gene Knockdown Techniques ,embryonic structures ,Cancer research ,Female ,Signal transduction ,Developmental Biology ,Research Paper - Abstract
This study aimed to determine the WNT2 expression in patients with severe preeclampsia and to explore the function of WNT2 dysregulation on the biological behaviors of trophoblast cells. The WNT2 and β-catenin expression in the patients with early-onset and late-onset severe preeclampsia and normal controls was determined. Subsequently, WNT2 was overexpressed and knocked down in HTR8 cells and WNT2 signaling pathway in regulating trophoblast cell proliferation, migration, invasion, and apoptosis were evaluated in vitro. The mRNA and protein expression levels of WNT2 and β-catenin were decreased in patients with preeclampsia, especially early-onset severe preeclampsia. Overexpression of WNT2 promoted trophoblast cell proliferation, migration, and invasion and inhibited apoptosis in vitro, whereas knockdown of WNT2 had opposite effects. The findings of this study reveal that WNT2 and β-catenin were decreased expressed in patients with preeclampsia. Decreased expression of WNT2 may inhibit trophoblast cell proliferation, migration, and invasion but induced apoptosis. WNT2 may serve as a promising biomarker for early detection of preeclampsia.
- Published
- 2020